Furamidine dihydrochloride is a cell-permeable, selective PRMT1 inhibitor that competitively targets the enzymes active site. It also exhibits minor groove DNA binding affinity for AT-rich sequences. This compound demonstrates anti-proliferative activity in various leukemia cell lines in vitro, supporting its use in oncology and epigenetics research.